
MTVA Market Capitalization Overview
Market Cap: $14.35M as of Jun 13, 2025
$14.35M
Past Month+$7.53M (110.41%)
As of Jun 13, 2025, MTVA has a market capitalization of $14.35M. Over the past 30 days, its market cap has increased by 66.63%, while in the last 12 months, it has decreased by -18.01%.
Market capitalization represents the total value of NeuroBo Pharmaceuticals Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
MTVA Market Cap Formula = Stock Price * Shares Outstanding
The market cap of MTVA helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of NeuroBo Pharmaceuticals Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
MTVA Market Cap Formula = Stock Price * Shares Outstanding
The market cap of MTVA helps investors assess the company's size and compare it with competitors for better investment decisions.
MTVA Market Cap & Key Trends
See NeuroBo Pharmaceuticals Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in MTVA
Order type
Buy in
Order amount
Est. shares
0 shares
MTVA Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $12.81M | +66.63% |
May 1, 2025 | $7.69M | -43.63% |
Apr 1, 2025 | $13.64M | +9.11% |
Mar 3, 2025 | $12.50M | -16.67% |
Feb 3, 2025 | $14.99M | -17.54% |
Jan 2, 2025 | $18.18M | -18.85% |
MTVA End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $14.35M | -18.01% |
2024 | $17.50M | -2.47% |
2023 | $17.94M | +2,712.78% |
2022 | $637.60K | -98.04% |
2021 | $32.53M | -68.50% |
2020 | $103.28M | — |
FAQs About NeuroBo Pharmaceuticals Inc (MTVA) Market Cap
As of Jun 13, 2025, the market capitalization of MTVA is $14.35M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, NeuroBo Pharmaceuticals Inc’s market capitalization has increased by 110.41%, changing from $6.82M to $14.35M as of Jun 13, 2025.
In the last 3 months, NeuroBo Pharmaceuticals Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, NeuroBo Pharmaceuticals Inc’s market capitalization decreased from $17.94M in January to $17.50M in December, reflecting a -2.47% change.
In the past five years, MTVA has had a compound annual growth rate (CAGR) of -29.89% in market capitalization. This means its market cap has shrunk at an average rate of -29.89% per year.